Review Article
Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis
Table 3
Data obtained from 200 MS patients treated with cy in our centre over a ten-year period. *of the fertile women.
| Side effects | % |
| Nausea and vomit | 40 | Amenorrhea | 18* | Transitory amenorrhea | 60* | Transitory azoospermia | 60 | Headache | 15 | Alopecia (reversible) | 13 | Fatigue | 10 | Diffuse pain | 8 | Cutaneous rash | 6 | Gastritis and diarrhoea | 6 | Bladder toxicity | 6 | Infection | 3 | Cancer risk | 1 | Arrhythmia | 1 | Dyspnoea | 0.5 |
|
|